US industry group HIMA (Health Industry Manufacturers Association) loses US Surgical:
This article was originally published in Clinica
US Surgical has left the Health Industry Manufacturers Association. Lou Mazzarese, the company's vice-president for quality and regulatory affairs, said the US trade group is simply too slow in making up its mind to be effective. HIMA's 40-member board of directors is too unwieldy to take a position on an issue on a timely basis, he said. Mr Mazzarese is a popular speaker who is often asked to appear as an industry representative at HIMA forums.
You may also be interested in...
The WHO’s new "living guideline" against remdesivir’s use in hospitalized patients notwithstanding, some key opinion leaders in India see a role for the antiviral, but underscore that COVID-19 is still in its infancy and all repurposed therapies for the disease still have a long way to go. They also see the US remdesivir studies as more robust.
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
A recent Department of Health and Human Services proposal to review regulations every 10 years may mean good things for the device industry, said David Hoffmeister, partner, Wilson Sonsini Goodrich & Rosati.